CTIS2023-504921-37-00进行中(未招募)1 期
A Study to Learn About the Study Medicine Called PF-07293893 in Healthy Adults, and How Different Doses of Study Medicine are Tolerated and Act in the Body.
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- Pfizer Inc.
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+(—)
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中(未招募)
1 期
A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called MidazolamCTIS2023-508518-40-00Pfizer Inc.16
已完成
不适用
Clinical Pharmacological Study to Investigate the Effects of Mucosta Ophthalmic Suspension UD2% on Ocular Surface Cells in Patients with Dry EyeDry eyeJPRN-UMIN000022629Otsuka Pharmaceutical Co., Ltd.15
进行中(未招募)
1 期
Prospective study to assess the emergence of drug resistance to oseltamivir following treatment of acute influenza A among children - Oseltamivir resistance studyInfluenza AEUCTR2005-005239-80-GBniversity Hospitals Leicester, Leicester General Hospital100
未知
1 期
Clinical pharmacology study to investigate the food effect on pharmacokinetics of TAS-102.Patients with solid tumorJPRN-jRCT2080221443Taiho Pharmaceutical Co., Ltd.16
已完成
不适用
The exploratory clinical study relates to the promoting effect and the safety of carbon dioxide transdermal absorption on the rehabilitation after total knee arthroplasty.OsteoarthritisJPRN-UMIN000019069Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine25
